Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
Abstract Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely used in therapy for the treatment of…
Abstract Cannabidiol (CBD), the main non-psychoactive component of Cannabis sativa L., is widely used in therapy for the treatment of…
Abstract Introduction: Alcohol, cannabis, and nicotine are commonly used psychoactive substances that affect adolescent neurocognition. Little is known about the…
Abstract Cannabis legalization continues to progress in the USA for medical and recreational purposes. G protein-coupled receptor 55 (GPR55) is…
Abstract Cannabidiol (CBD) is a promising drug candidate with pleiotropic pharmacological activity, whose low aqueous solubility and unfavorable pharmacokinetics have…
Abstract The proportion of older adults using medical cannabis is rising. Therefore, we aimed to assess the effects of herbal…
Abstract Synthetic cannabinoid receptor agonists (SCRAs) have become a wide group of new psychoactive substances since the 2010s. For the…
Abstract Introduction: The legalization of cannabidiol (CBD) across the United States, in varying degrees, has made CBD easily accessible to…
Abstract Cannabis, the most consumed illicit psychoactive drug in the world, is increasingly used by pregnant women. However, while cannabinoid…
Abstract Cannabidiol (CBD) is a promising natural agent for treating psoriasis. CBD activity is attributed to inhibition of NF-kB, IL-1β,…
Abstract Background: The causal impacts of recreational cannabis legalization are not well understood due to the number of potential confounds.…